HOME >> MEDICINE >> NEWS
Newly developed treatment for severe grief shown more effective than standard therapy

A recently developed method for treating complicated grief, which includes discussing certain aspects of the death of a loved one, was found more effective than a standard therapy for depression, according to a study in the June 1 issue of JAMA.

Many physicians are uncertain about how to identify bereaved individuals who need treatment, and what treatments work for bereavement-related mental health problems, according to background information in the article. Bereavement-related major depressive disorder (MDD) is a well-recognized consequence of loss. Complicated grief also occurs in the aftermath of loss but is different from depression. Key features of complicated grief, persisting more than 6 months after the death of a loved one, include (1) a sense of disbelief regarding the death; (2) anger and bitterness over the death; (3) recurrent pangs of painful emotions, with intense yearning and longing for the deceased; and (4) preoccupation with thoughts of the loved one, often including distressing intrusive thoughts related to the death.

Complicated grief is a source of significant distress and impairment and is associated with a range of negative health consequences, but the results of existing treatments for it have been disappointing. Prevalence rates are estimated at approximately 10 percent to 20 percent of bereaved persons. Approximately 2.5 million people die yearly in the United States. Estimates suggest each death leaves an average of 5 people bereaved, suggesting that more than 1 million people per year are expected to develop complicated grief in the United States.

Given observations regarding the specificity and clinical significance of complicated grief symptoms, including the lack of response to standard treatments for depression, the researchers developed a targeted complicated grief treatment (CGT). They modified standard interpersonal psychotherapy (IPT) for grief-related depression to include cognitive-behavioral th
'"/>

Contact: Lisa Rossi
412-647-3555
JAMA and Archives Journals
31-May-2005


Page: 1 2 3

Related medicine news :

1. Newly discovered behavior in cancer cells signals dangerous metastasis
2. Newly discovered killer cell fights cancer
3. Newly discovered gene may predict aggressive ovarian cancer
4. Newly published summer camp health guideline advises parents, camp directors
5. Newly discovered branding process helps immune system cells pick their fights
6. Clinical guidelines for blood conservation during cardiac procedures developed
7. Tequila raw ingredient being developed into drug-carrier that targets colon diseases
8. Probe to detect spread of breast cancer co-developed by UH scientist
9. Faster, more accurate tuberculosis test developed
10. Anthrax detector developed
11. Standard developed for collection of suspicious powders

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 28, 2017 , ... Datta Endoscopic Back Surgery and Pain ... endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with additional ... eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back surgery ...
(Date:4/28/2017)... MA (PRWEB) , ... April 28, 2017 , ... People ... for older people. “Wearing a hearing aid doesn’t have the stigma it had when ... & Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec ... Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their ... expert that specializes in long-term care, Brooke Grove now has the capability to ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins ... athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 24, 2017 Solentim, the developer of ... addition of a major new product line called ... The VIPS has been developed for automatically seeding ... as part of the process to generate clonally-derived ... and more reliable solution when compared to traditional ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
Breaking Medicine Technology:
Cached News: